Evolutionary action and structural basis of the allosteric switch controlling β2AR functional selectivity
暂无分享,去创建一个
Angela D. Wilkins | Olivier Lichtarge | Michel Bouvier | Martin J. Lohse | Marek Kimmel | Christian Le Gouill | Jonathan Gallion | Wayne Stallaert | O. Lichtarge | M. Kimmel | M. Lohse | A. Wilkins | M. Bouvier | C. Le Gouill | Jonathan Gallion | Martin Audet | Martin Audet | Wayne Stallaert | Anne-Marie Schönegge | Louis-Philippe Picard | Anne-Marie Schönegge | L. Picard | Louis-Philippe Picard
[1] C. Costa-Neto,et al. Recent updates on GPCR biased agonism. , 2016, Pharmacological research.
[2] A. J. Venkatakrishnan,et al. Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region , 2016, Nature.
[3] O. Lichtarge,et al. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation , 2016, Proceedings of the National Academy of Sciences.
[4] S. Grzesiek,et al. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor , 2016, Nature.
[5] L. Bohn,et al. Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery , 2016 .
[6] D. Devost,et al. Cellular and subcellular context determine outputs from signaling biosensors. , 2016, Methods in cell biology.
[7] Y. Liu,et al. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways. , 2015, The Biochemical journal.
[8] A. J. Venkatakrishnan,et al. Universal allosteric mechanism for Gα activation by GPCRs , 2015, Nature.
[9] T. Schwartz,et al. Biased Gs Versus Gq Proteins and β-Arrestin Signaling in the NK1 Receptor Determined by Interactions in the Water Hydrogen Bond Network* , 2015, The Journal of Biological Chemistry.
[10] Stephen M. Husbands,et al. Structural insights into μ-opioid receptor activation , 2015, Nature.
[11] T. S. Kobilka,et al. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling , 2015, Cell.
[12] Angela D. Wilkins,et al. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor , 2015, Proceedings of the National Academy of Sciences.
[13] Steffen Wolf,et al. Sequence, Structure and Ligand Binding Evolution of Rhodopsin-Like G Protein-Coupled Receptors: A Crystal Structure-Based Phylogenetic Analysis , 2015, PloS one.
[14] Olivier Lichtarge,et al. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. , 2015, Cancer research.
[15] Olivier Lichtarge,et al. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. , 2015, Cancer research.
[16] Garth J. Williams,et al. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser , 2014, Nature.
[17] Angela D. Wilkins,et al. Determinants of Endogenous Ligand Specificity Divergence among Metabotropic Glutamate Receptors* , 2014, The Journal of Biological Chemistry.
[18] Thomas O. McDonald,et al. Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence , 2014, Molecular Cancer Therapeutics.
[19] A. Shukla,et al. Emerging structural insights into biased GPCR signaling. , 2014, Trends in biochemical sciences.
[20] O. Lichtarge,et al. A formal perturbation equation between genotype and phenotype determines the Evolutionary Action of protein-coding variations on fitness , 2014, Genome research.
[21] Helmut Grubmüller,et al. Position of transmembrane helix 6 determines receptor G protein coupling specificity. , 2014, Journal of the American Chemical Society.
[22] J. Hardelin,et al. Biased signaling through G‐protein‐coupled PROKR2 receptors harboring missense mutations , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Benjamin G Tehan,et al. Unifying family A GPCR theories of activation. , 2014, Pharmacology & therapeutics.
[24] Arthur Christopoulos,et al. Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy , 2014, Molecular Pharmacology.
[25] J. Benovic,et al. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein , 2013, Proceedings of the National Academy of Sciences.
[26] Angela D. Wilkins,et al. Accounting for epistatic interactions improves the functional analysis of protein structures , 2013, Bioinform..
[27] R. Stevens,et al. Structural Features for Functional Selectivity at Serotonin Receptors , 2013, Science.
[28] Arthur Christopoulos,et al. Signalling bias in new drug discovery: detection, quantification and therapeutic impact , 2012, Nature Reviews Drug Discovery.
[29] M. Babu,et al. Molecular signatures of G-protein-coupled receptors , 2013, Nature.
[30] Albert C. Pan,et al. The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.
[31] J. Wess,et al. Design and Functional Characterization of a Novel, Arrestin-Biased Designer G Protein-Coupled Receptor , 2012, Molecular Pharmacology.
[32] Michel Bouvier,et al. Restructuring G-Protein- Coupled Receptor Activation , 2012, Cell.
[33] B. Kobilka,et al. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor. , 2012, Structure.
[34] Angela D. Wilkins,et al. The use of evolutionary patterns in protein annotation. , 2012, Current opinion in structural biology.
[35] X. Deupí,et al. Conserved activation pathways in G-protein-coupled receptors. , 2012, Biochemical Society transactions.
[36] Kurt Wüthrich,et al. Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR , 2012, Science.
[37] Albert C. Pan,et al. Activation mechanism of the β2-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[38] R. Lefkowitz,et al. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. , 2011, Trends in biochemical sciences.
[39] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[40] Gaël Varoquaux,et al. The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.
[41] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[42] Michel Bouvier,et al. Multiplexing of multicolor bioluminescence resonance energy transfer. , 2010, Biophysical journal.
[43] Thomas M. Frimurer,et al. Conserved Water-mediated Hydrogen Bond Network between TM-I, -II, -VI, and -VII in 7TM Receptor Activation* , 2010, The Journal of Biological Chemistry.
[44] Olivier Lichtarge,et al. Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptors , 2010, Proceedings of the National Academy of Sciences.
[45] S. Erdin,et al. Evolutionary trace annotation of protein function in the structural proteome. , 2010, Journal of molecular biology.
[46] L. Pardo,et al. Ligand-specific regulation of the extracellular surface of a G protein coupled receptor , 2009, Nature.
[47] P. Labute. proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization , 2013 .
[48] M. Bouvier,et al. Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the β1-Adrenergic Receptor , 2008, Molecular Pharmacology.
[49] Nagarajan Vaidehi,et al. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.
[50] R. Stevens,et al. GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.
[51] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[52] M. Bouvier,et al. The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.
[53] Hyunsoo Kim,et al. Sparse Non-negative Matrix Factorizations via Alternating Non-negativity-constrained Least Squares , 2006 .
[54] S. Milano,et al. Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.
[55] Leonardo Pardo,et al. The Role of Internal Water Molecules in the Structure and Function of the Rhodopsin Family of G Protein‐Coupled Receptors , 2007, Chembiochem : a European journal of chemical biology.
[56] Olivier Lichtarge,et al. β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor* , 2006, Journal of Biological Chemistry.
[57] Olivier Lichtarge,et al. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. , 2006, The Journal of biological chemistry.
[58] Michel Bouvier,et al. Real-time monitoring of receptor and G-protein interactions in living cells , 2005, Nature Methods.
[59] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[60] O. Lichtarge,et al. A family of evolution-entropy hybrid methods for ranking protein residues by importance. , 2004, Journal of molecular biology.
[61] Pascale G. Charest,et al. β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[62] Pascale G. Charest,et al. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[63] Harel Weinstein,et al. Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor , 2002, The Journal of Biological Chemistry.
[64] E. Lakatta,et al. β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.
[65] E. Lakatta,et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. , 2002, The Journal of biological chemistry.
[66] M. Caron,et al. Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization* , 1999, The Journal of Biological Chemistry.
[67] H. Sebastian Seung,et al. Learning the parts of objects by non-negative matrix factorization , 1999, Nature.
[68] F. Cohen,et al. An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.
[69] M. Caron,et al. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. , 1995, Biochemistry.
[70] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[71] T. S. Kobilka,et al. Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.